Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial.

Rajendram, R; Taylor, P; Wilson, V; Harris, N; Morris, O; Tomlinson, M; Yarrow, S; Garrott, H; Herbert, H; Dick, A; Cook, A; Gattamaneni, Rao; Jain, R; Olver, J; Hurel, S; Bremner, F; Drummond, S; Kemp, E; Ritchie, D; Rumsey, N; Morris, D; Lane, C; Palaniappan, N; Li, C; Pell, J; Hills, R; Ezra, D; Potts, M; Jackson, S; Rose, G; Plowman, N; Bunce, C; Uddin, J; Lee, R; Dayan, C

Affiliation

Moorfields Eye Hospital NHS Foundation Trust, London, UK

Issue Date

2018-01-30

Metadata

Show full item record

Abstract

Standard treatment for thyroid eye disease is with systemic corticosteroids. We aimed to establish whether orbital radiotherapy or antiproliferative immunosuppression would confer any additional benefit.

Citation

Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial. 2018, Lancet Diabetes Endocrinol

Journal

The Lancet, Diabetes & Endocrinology

URI

http://hdl.handle.net/10541/620847

DOI

10.1016/S2213-8587(18)30021-4

PubMed ID

29396245

Type

Article

Language

ISSN

2213-8595

Collections

All Christie Publications